Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC Trial.

Novello, Silvia; Cheng, Ying; Spigel, David; Fang, Jian; Chen, Yuanbin; Zenke, Yoshikata; Lee, Ki; Navarro, Alejandro; Buchmeier, Eva; Wen-Cheng Chang, John; Shiraishi, Yoshimasa; Özgüroğlu, MUSTAFA; Kim, Yu; Thai Hoa, Nguyen; Hashemi, Sayed; Chiang, Anne; Turner, Ralph; Mann, Helen; Olivo, Yuka; Jiang, Haiyi; Senan, Suresh

doi:10.1016/j.jtho.2026.103564

Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC Trial.

Novello S., Cheng Y., Spigel D., Fang J., Chen Y., Zenke Y., ...Daha Fazla

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, ss.103564, 2026 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası:
Basım Tarihi: 2026
Doi Numarası: 10.1016/j.jtho.2026.103564
Dergi Adı: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.103564
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır